NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity
Estimated value
£251.9m
Awarded value
£251.9m
Suppliers
1
Lots
1
Published
01 Oct 2019
Description
NHS Framework for the NHS London Region, Branded Medicines - Tranche B, Cytokine Modulators and other monoclonal Antibodies, and Antiretrovirals Offer reference number: CM/PHR/16/5515/01 - 1 September 2019 to 31 August 2021 - NHS Framework for the NHS London Region, Branded Medicines - Tranche B with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/16/5515/02 - 1 September 2019 to 31 August 2020 - NHS Framework for the NHS London Region, Branded Medicines - Annual Tranche - Cytokine Modulators and other monoclonal antibodies with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/16/5515/03 - 1 September 2019 to 31 August 2020 - NHS Framework for the NHS London Region, Branded Medicines - Antiretrovirals with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months
Scope
- Reference
- tender_200934/801711
- Total value
- £251,930,337 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Aug 2019 to 30 Aug 2020
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 03 Apr 2019, 11:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£251.9m
Award date
04 Jul 2019
Contract start
31 Aug 2019
Contract end
30 Aug 2020